RYAH) Smart Dry Herb Inhaler Delivers Consistent, Predictable Results


Receive instant alerts for news on your actions. Claim your 1-week free trial for Street Insider Premium here.


RYAH Group (CSE: RYAH) develops innovative IoT products that capture powerful insight into data and has a mission to transform patient care by using big data and AI to reshape the understanding and uses of herbal medicines. The company’s devices and data are used by a growing number of participants in herbal clinical trials around the world, including clinical research on the relationship between medical cannabis use and cancer treatment, which is in its very early stages. “Two key constraints that have limited the viability of studies of cannabis in an oncological setting are the highly variable nature of the cannabis plant and the traditional methods of cannabis consumption which make cannabis use difficult to measure,” explains an article. recent. “The RYAH Group intends to address this issue with the launch of its proprietary RYAH Smart Dry Herb inhaler. The product is the first dry herb inhaler that tracks and controls the amount inhaled, providing consistent and predictable results. The inhaler connects to the RYAH Health app… In addition, the device also enables a post-session review mechanism that collects session data, an essential requirement for any clinical study.

To view the full article, visit https://ibn.fm/7s5t1

About RYAH Group Inc.

RYAH is a connected devices and big data and technology company focused on predictive analytics valuable to the global herbal medicine and nutraceutical industry. Its robust artificial intelligence platform aggregates and correlates patient data compliant with the Health Insurance Portability and Accountability Act (HIPAA), which aims to help physicians and patients personalize herbal treatments for better predict treatment results. Data collection is relevant for clinics, physicians, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage the effects of the formulation on patients and demographics. With a strong intellectual property portfolio, RYAH brings together in-depth and insightful data on the complete patient session and formulation lifecycle. For more information visit www.RYAHGroup.com.

NOTICE TO INVESTORS: The latest news and updates relating to the RYAH Group are available in the Company’s press room at https://ibn.fm/RYAH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements delivered in multiple languages, we’ve got the wire-quality delivery products you’ll need to make sure your next press release grabs the attention of your target audience and doesn’t let go. While our competitors seek to offer you hidden fees and restrictive word limits, InvestorWire is keeping things transparent. We offer UNLIMITED Words on all national outings. While other communications services can provide a basic review of your release, InvestorWire helps you do your best with Improved press release.

At our competitors, the job is done the second your exit goes on the wire. Not with InvestorWire. We include follow-up coverage of every release taking advantage of the ever-growing audience for the 50+ brands who make up the InvestorBrandNetwork.

Make the most of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please review the full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever posted or republished: http://ibn.fm/ Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, California 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of InvestorBrandNetwork.


Source link

Comments are closed.